Loading clinical trials...
Loading clinical trials...
Phase IIa Randomized, Single-Blinded, Placebo-Controlled Clinical Trial of the Reprofiled Drug Auranofin for GI Protozoa
Conditions
Interventions
Auranofin
Placebo
Locations
2
Bangladesh
International Center for Diarrheal Disease Research Bangladesh - Parasitology
Dhaka, Bangladesh
Rajshahi Medical College Hospital
Rajshahi, Bangladesh
Start Date
November 6, 2016
Primary Completion Date
March 10, 2021
Completion Date
March 10, 2021
Last Updated
January 26, 2023
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions